Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 6/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.42 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.42 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL8675242 | 0.88 | PRKCA (0.56) | PRKCATDP1PRKCEPRKCQPRKCD | |
| SCHEMBL77521 | 0.87 | PRKCA (0.59) | PRKCATDP1PRKCEPRKCQPRKCD | |
| SCHEMBL7758874 | 0.87 | PRKCA (0.59) | PRKCATDP1PRKCEPRKCQPRKCD | |
| SCHEMBL7759898 | 0.87 | PRKCA (0.59) | PRKCATDP1PRKCEPRKCQPRKCD | |
| Triacetin SCHEMBL22160048 | 0.85 | PRKCA (0.57) | PRKCATDP1PRKCEPRKCQPRKCD | |
| SCHEMBL30585906 | 0.85 | PRKCA (0.48) | PRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL2266760 | 0.85 | PRKCA (0.48) | PRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL4879570 | 0.83 | PRKCA (0.56) | PRKCAPRKCEPRKCQPRKCD | |
| Ethylene Glycol SCHEMBL16612582 | 0.83 | PRKCA (0.56) | PRKCATDP1PRKCEPRKCQPRKCD | |
| Isopropyl Alcohol SCHEMBL11286605 | 0.82 | PRKCA (0.54) | PRKCATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118870995-A | Volatile material device, use and method relating thereto | 威·曼父子有限公司 | 2024-10-29 | — | — | CN | disclosed |
| EP-2491918-B1 | Polyglyceryl compounds and compositions | JOHNSON & JOHNSON CONSUMER (US) | 2015-05-06 | — | — | EP | disclosed |
| EP-2491916-B1 | Polyglyceryl compounds and compositions | JOHNSON & JOHNSON CONSUMER (US) | 2015-03-11 | — | — | EP | disclosed |
| EP-2491917-B1 | Polyglyceryl compounds and compositions | JOHNSON & JOHNSON CONSUMER (US) | 2014-12-17 | — | — | EP | disclosed |
| US-8778864-B2 | Polyglyceryl compounds and compositions | JOHNSON & JOHNSON CONSUMER COMPANIES, INC. (US) | 2014-07-15 | — | — | US | disclosed |
| US-8455418-B2 | Polyglyceryl compounds comprising a methyl glucoside or sorbitan remnant and compositions containing same | JOHNSON & JOHNSON CONSUMER COMPANIES, INC. (US) | 2013-06-04 | — | — | US | disclosed |
| US-8394755-B2 | Polyglyceryl compounds and compositions | JOHNSON & JOHNSON CONSUMER COMPANIES, INC. (US) | 2013-03-12 | — | — | US | disclosed |
| EP-2491917-A1 | Polyglyceryl compounds and compositions | Johnson & Johnson Consumer Companies Inc. (US) | 2012-08-29 | — | — | EP | disclosed |
| EP-2491918-A1 | Polyglyceryl compounds and compositions | Johnson & Johnson Consumer Companies Inc. (US) | 2012-08-29 | — | — | EP | disclosed |
| EP-2491916-A1 | Polyglyceryl compounds and compositions | Johnson & Johnson Consumer Companies Inc. (US) | 2012-08-29 | — | — | EP | disclosed |
| US-8211850-B2 | Polyglyceryl compounds and compositions | JOHNSON & JOHNSON CONSUMER COMPANIES, INC. (US) | 2012-07-03 | — | — | US | disclosed |
| US-20120122755-A1 | POLYGLYCERYL COMPOUNDS AND COMPOSITIONS | JOHNSON & JOHNSON CONSUMER INC. | 2012-05-17 | — | — | US | disclosed |
| US-20120122758-A1 | POLYGLYCERYL COMPOUNDS AND COMPOSITIONS | KENVUE BRANDS LLC | 2012-05-17 | — | — | US | disclosed |
| US-20120123103-A1 | POLYGLYCERYL COMPOUNDS AND COMPOSITIONS | KENVUE BRANDS LLC | 2012-05-17 | — | — | US | disclosed |
| US-20120123104-A1 | POLYGLYCERYL COMPOUNDS AND COMPOSITIONS | KENVUE BRANDS LLC | 2012-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120123104-A1 | POLYGLYCERYL COMPOUNDS AND COMPOSITIONS | PHOSPHO1, SGMS1, SGMS2 | PRKCA 2464/4885TDP1 1260/4885PRKCE 2526/4885 |
| US-20120122755-A1 | POLYGLYCERYL COMPOUNDS AND COMPOSITIONS | PHOSPHO1, SGMS1, SGMS2 | PRKCA 2464/4885TDP1 1260/4885PRKCE 2526/4885 |
| US-20120122758-A1 | POLYGLYCERYL COMPOUNDS AND COMPOSITIONS | PHOSPHO1, SGMS1, SGMS2 | PRKCA 2464/4885TDP1 1260/4885PRKCE 2526/4885 |
| US-20120123103-A1 | POLYGLYCERYL COMPOUNDS AND COMPOSITIONS | PHOSPHO1, SGMS1, SGMS2 | PRKCA 2464/4885TDP1 1260/4885PRKCE 2526/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.